Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia.

Bach PB, Malak SF, Jurcic J, Gelfand SE, Eagan J, Little C, Sepkowitz KA.

Infect Control Hosp Epidemiol. 2002 Aug;23(8):471-4.

PMID:
12186216
2.

Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.

Lloyd-Smith P, Younger J, Lloyd-Smith E, Green H, Leung V, Romney MG.

J Hosp Infect. 2013 Sep;85(1):54-9. doi: 10.1016/j.jhin.2013.06.016. Epub 2013 Aug 6.

PMID:
23920443
3.

Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.

Almyroudis NG, Lesse AJ, Hahn T, Samonis G, Hazamy PA, Wongkittiroch K, Wang ES, McCarthy PL Jr, Wetzler M, Segal BH.

Infect Control Hosp Epidemiol. 2011 May;32(5):490-6. doi: 10.1086/659408.

PMID:
21515980
4.

Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.

Gearhart M, Martin J, Rudich S, Thomas M, Wetzel D, Solomkin J, Hanaway MJ, Aranda-Michel J, Weber F, Trumball L, Bass M, Zavala E, Steve Woodle E, Buell JF.

Clin Transplant. 2005 Dec;19(6):711-6.

PMID:
16313314
5.

Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.

Mauldin PD, Salgado CD, Durkalski VL, Bosso JA.

Ann Pharmacother. 2008 Mar;42(3):317-26. doi: 10.1345/aph.1K501. Epub 2008 Feb 19.

PMID:
18285560
6.

Vancomycin-resistant enterococci colonization does not increase mortality in end-stage kidney failure: a case-control study.

Garner SE, Polkinghorne KR, Kotsanas D, Kerr PG, Korman TM, Stuart RL.

J Hosp Infect. 2013 Dec;85(4):289-96. doi: 10.1016/j.jhin.2013.09.005. Epub 2013 Sep 21.

PMID:
24161798
7.

Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.

Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY.

J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.

PMID:
18473099
8.

Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.

Worth LJ, Thursky KA, Seymour JF, Slavin MA.

Eur J Haematol. 2007 Sep;79(3):226-33. Epub 2007 Jul 26.

PMID:
17655696
10.

Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.

Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP.

Infect Control Hosp Epidemiol. 2001 Jul;22(7):437-42.

PMID:
11583213
11.

Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.

Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1054-9. Epub 2007 Jul 12.

PMID:
17932826
12.

Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.

Lodise TP, McKinnon PS, Tam VH, Rybak MJ.

Clin Infect Dis. 2002 Apr 1;34(7):922-9. Epub 2002 Mar 4.

13.

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH.

Diagn Microbiol Infect Dis. 2000 Mar;36(3):145-58.

PMID:
10729656
14.

Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis.

Barbosa D, Lima L, Silbert S, Sader H, Cendoroglo M, Draibe S, Camargo L, Vianna L, Belasco A, Sesso R.

Am J Kidney Dis. 2004 Aug;44(2):337-43.

PMID:
15264193
15.
16.

[Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].

Atalay S, Ece G, Samlıoğlu P, Maraş G, Köse I, Köse S.

Mikrobiyol Bul. 2012 Oct;46(4):553-9. Turkish.

PMID:
23188569
17.
18.

The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.

Salgado CD.

Am J Infect Control. 2008 Dec;36(10):S175.e5-8. doi: 10.1016/j.ajic.2008.10.010.

PMID:
19084155
19.

Vancomycin-resistant Enterococcus in liver transplant patients.

Orloff SL, Busch AM, Olyaei AJ, Corless CL, Benner KG, Flora KD, Rosen HR, Rabkin JM.

Am J Surg. 1999 May;177(5):418-22.

PMID:
10365883
20.

Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.

Olivier CN, Blake RK, Steed LL, Salgado CD.

Infect Control Hosp Epidemiol. 2008 May;29(5):404-9. doi: 10.1086/587647.

PMID:
18419361
Items per page

Supplemental Content

Write to the Help Desk